Young cancer survivors face accelerated biological aging and cognitive decline linked to chemotherapy treatments

Researchers find that chemotherapy and cancer treatment can speed up biological aging and cause cognitive decline in young survivors.

By: AXL Media

Published: Mar 3, 2026, 5:37 AM EST

Source: The information in this article was sourced from University of Rochester Medical Center

The Discovery of Accelerated Biological Aging

New findings published in Nature Communications reveal that individuals who survive cancer during their youth exhibit signs of advanced aging that do not align with their chronological age. This process is visible both within the structure of their cells and in the functional performance of their brains. The study, which included approximately 1,400 participants, suggests that the physiological toll of surviving the disease creates a different aging trajectory than that seen in the general population.

Impact of Chemotherapy on Cellular Integrity

The research team identified chemotherapy as the most significant factor in driving this accelerated aging process. Because chemotherapy is designed to alter DNA structure to combat malignancy, it can lead to widespread cellular damage that persists long after treatment concludes. This phenomenon was observed across various cancer types, though it was most prominent in survivors of acute lymphoblastic leukemia and Hodgkin lymphoma who had been off therapy for at least five years.

Cognitive Consequences and Professional Challenges

Accelerated biological aging is closely linked to measurable declines in neurocognitive function, specifically affecting memory, attention, and information processing. AnnaLynn Williams, a lead researcher on the study, noted that these challenges often hit survivors at a critical life stage. As young adults attempt to finish their education and launch careers, cognitive difficulties can lead to worse employment outcomes compared to their siblings or peers who did not undergo cancer treatment.